.Nature Medicine, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medication conjugate (ADC) tisotumab vedotin caused enhanced progression-free and also total survival, leading to FDA approval as well as a brand-new treatment choice for people.